Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hangzhou Qinyuan Natural Plant High-tech is a prominent Chinese biotechnology firm specializing in the research, development, and industrial-scale production of high-purity natural plant extracts. Established in 1998, the company has built a reputation as a leading global supplier of Resveratrol and Polydatin, primarily sourced from Polygonum cuspidatum. Their operations integrate advanced extraction, separation, and purification technologies to deliver active ingredients for the pharmaceutical, nutraceutical, and cosmetic industries. Qinyuan's facilities adhere to rigorous quality control standards, ensuring their botanical products meet international regulatory requirements. The company continues to innovate in the field of natural product chemistry, focusing on the health benefits of traditional medicinal plants through a high-tech lens.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hangzhou Qinyuan Natural Plant High-tech.